- Home
- BNR vs AIRE Comparison
BNR vs AIRE Comparison
Compare BNR & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- AIRE
- Stock Information
- Founded
- BNR 2014
- AIRE 2021
- Country
- BNR China
- AIRE United States
- Employees
- BNR N/A
- AIRE N/A
- Industry
- BNR Medical Specialities
- AIRE
- Sector
- BNR Health Care
- AIRE
- Exchange
- BNR Nasdaq
- AIRE Nasdaq
- Market Cap
- BNR 38.3M
- AIRE 39.4M
- IPO Year
- BNR 2020
- AIRE N/A
- Fundamental
- Price
- BNR $8.37
- AIRE $1.20
- Analyst Decision
- BNR
- AIRE Hold
- Analyst Count
- BNR 0
- AIRE 1
- Target Price
- BNR N/A
- AIRE N/A
- AVG Volume (30 Days)
- BNR 38.7K
- AIRE 32.0M
- Earning Date
- BNR 09-08-2025
- AIRE 11-11-2025
- Dividend Yield
- BNR N/A
- AIRE N/A
- EPS Growth
- BNR N/A
- AIRE N/A
- EPS
- BNR N/A
- AIRE N/A
- Revenue
- BNR $74,862,782.00
- AIRE $3,043,657.00
- Revenue This Year
- BNR $136.32
- AIRE $410.32
- Revenue Next Year
- BNR N/A
- AIRE $166.28
- P/E Ratio
- BNR N/A
- AIRE N/A
- Revenue Growth
- BNR 5.20
- AIRE 2973.28
- 52 Week Low
- BNR $2.18
- AIRE $0.14
- 52 Week High
- BNR $11.12
- AIRE $4.49
- Technical
- Relative Strength Index (RSI)
- BNR 51.90
- AIRE 72.30
- Support Level
- BNR $8.02
- AIRE $1.13
- Resistance Level
- BNR $9.55
- AIRE $1.42
- Average True Range (ATR)
- BNR 0.67
- AIRE 0.19
- MACD
- BNR -0.15
- AIRE 0.08
- Stochastic Oscillator
- BNR 30.29
- AIRE 57.72
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.